TrialJournal of atherosclerosis and thrombosis2022

Prevention of Cardiovascular Events with Pitavastatin is Associated with Increased Serum Lipoprotein Lipase Mass Level: Subgroup Analysis of the TOHO-LIP.

Daiji Nagayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.